Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Control of HIV latency by epigenetic and non-epigenetic mechanisms.

Mbonye U, Karn J.

Curr HIV Res. 2011 Dec 1;9(8):554-67.

2.

The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit.

Karn J.

Curr Opin HIV AIDS. 2011 Jan;6(1):4-11. doi: 10.1097/COH.0b013e328340ffbb. Review.

3.

Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure.

Mbonye U, Karn J.

Virology. 2014 Apr;454-455:328-39. doi: 10.1016/j.virol.2014.02.008. Epub 2014 Feb 22. Review.

4.

The Molecular Basis for Human Immunodeficiency Virus Latency.

Mbonye U, Karn J.

Annu Rev Virol. 2017 Sep 29;4(1):261-285. doi: 10.1146/annurev-virology-101416-041646. Epub 2017 Jul 17. Review.

PMID:
28715973
5.

T-cell receptor signaling enhances transcriptional elongation from latent HIV proviruses by activating P-TEFb through an ERK-dependent pathway.

Kim YK, Mbonye U, Hokello J, Karn J.

J Mol Biol. 2011 Jul 29;410(5):896-916. doi: 10.1016/j.jmb.2011.03.054.

6.

The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.

Mousseau G, Kessing CF, Fromentin R, Trautmann L, Chomont N, Valente ST.

MBio. 2015 Jul 7;6(4):e00465. doi: 10.1128/mBio.00465-15.

7.

HIV-1 latency in actively dividing human T cell lines.

Jeeninga RE, Westerhout EM, van Gerven ML, Berkhout B.

Retrovirology. 2008 Apr 25;5:37. doi: 10.1186/1742-4690-5-37.

8.

Lost in transcription: molecular mechanisms that control HIV latency.

Taube R, Peterlin M.

Viruses. 2013 Mar 21;5(3):902-27. doi: 10.3390/v5030902. Review.

9.

Regulation of human immunodeficiency virus-1 latency and its reactivation.

Verdin E.

Bull Mem Acad R Med Belg. 2008;163(6):355-64; discussion 364-5.

PMID:
19445107
10.

The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation.

Li Z, Guo J, Wu Y, Zhou Q.

Nucleic Acids Res. 2013 Jan 7;41(1):277-87. doi: 10.1093/nar/gks976. Epub 2012 Oct 18.

11.

Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency.

Pearson R, Kim YK, Hokello J, Lassen K, Friedman J, Tyagi M, Karn J.

J Virol. 2008 Dec;82(24):12291-303. doi: 10.1128/JVI.01383-08. Epub 2008 Oct 1.

12.

Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo.

Hermankova M, Siliciano JD, Zhou Y, Monie D, Chadwick K, Margolick JB, Quinn TC, Siliciano RF.

J Virol. 2003 Jul;77(13):7383-92.

13.

NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.

Williams SA, Chen LF, Kwon H, Ruiz-Jarabo CM, Verdin E, Greene WC.

EMBO J. 2006 Jan 11;25(1):139-49. Epub 2005 Dec 1.

14.

Latency: the hidden HIV-1 challenge.

Marcello A.

Retrovirology. 2006 Jan 16;3:7. Review.

15.

Molecular mechanisms of HIV latency.

Cary DC, Fujinaga K, Peterlin BM.

J Clin Invest. 2016 Feb;126(2):448-54. doi: 10.1172/JCI80565. Epub 2016 Jan 5. Review.

16.

Transcriptional profiles of latent human immunodeficiency virus in infected individuals: effects of Tat on the host and reservoir.

Lin X, Irwin D, Kanazawa S, Huang L, Romeo J, Yen TS, Peterlin BM.

J Virol. 2003 Aug;77(15):8227-36.

17.

Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.

Colin L, Van Lint C.

Retrovirology. 2009 Dec 4;6:111. doi: 10.1186/1742-4690-6-111. Review.

18.

Anti-viral opportunities during transcriptional activation of latent HIV in the host chromatin.

Mujtaba S, Zhou MM.

Methods. 2011 Jan;53(1):97-101. doi: 10.1016/j.ymeth.2010.09.001. Epub 2010 Sep 7. Review.

19.

Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication.

Tyagi M, Bukrinsky M.

Mol Med. 2012 Sep 25;18:1096-108. doi: 10.2119/molmed.2012.00194. Review.

20.

The multifactorial nature of HIV-1 latency.

Lassen K, Han Y, Zhou Y, Siliciano J, Siliciano RF.

Trends Mol Med. 2004 Nov;10(11):525-31. Review.

PMID:
15519278

Supplemental Content

Support Center